| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.921 | 4.557 | 4.610 | 11.169 | 17.068 | 16.159 | 10.530 | 7.981 | 11.231 | 11.937 |
| Total Income - EUR | 4.921 | 4.557 | 4.610 | 11.169 | 17.068 | 17.450 | 10.530 | 7.981 | 11.231 | 11.940 |
| Total Expenses - EUR | 6.175 | 6.665 | 6.814 | 7.181 | 11.581 | 11.380 | 8.582 | 10.422 | 8.529 | 13.116 |
| Gross Profit/Loss - EUR | -1.254 | -2.108 | -2.204 | 3.987 | 5.486 | 6.070 | 1.948 | -2.440 | 2.702 | -1.176 |
| Net Profit/Loss - EUR | -1.401 | -2.200 | -2.250 | 3.876 | 5.316 | 5.922 | 1.843 | -2.520 | 2.592 | -1.534 |
| Employees | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Bio Test & Solutions (Bt & S) Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 138 | 120 | 116 | 2.031 | 3.681 | 4.462 | 5.905 | 381 | 1.351 | 451 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 1.588 | 3.437 | 4.152 | 261 | 220 | 220 | 217 |
| Cash | 138 | 120 | 116 | 443 | 244 | 310 | 5.644 | 161 | 1.132 | 234 |
| Shareholders Funds | -7.199 | -9.325 | -11.417 | -7.332 | -1.874 | 4.083 | 5.835 | -2.472 | 128 | -1.406 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 7.336 | 9.444 | 11.533 | 9.363 | 5.555 | 379 | 70 | 2.853 | 1.223 | 1.857 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8559 - 8559" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Bio Test & Solutions (Bt & S) Srl